Stock Elyse
Insider CIK 1785732 · BHVN Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 7,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 9,750 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 3,375 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 3,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 45,666 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,548 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 8,452 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 7,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 10,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 10,358 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 1,180 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 3,084 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 6,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 25,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 27,602 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,398 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 25,225 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 775 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 938 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 5,374 | $148.50 | $798.0K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 11,090 | $148.50 | $1.65M | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-10 | 2022-01-12 | 937 | — | $0 | 938 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-10 | 2022-01-12 | 937 | — | $0 | 5,374 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 13,000 | — | $0 | 13,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-07 | 2022-01-07 | 26,000 | — | $0 | 26,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-07 | 2022-01-07 | 3,250 | — | $0 | 9,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 4,000 | — | $0 | 4,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-07 | 2022-01-07 | 1,000 | — | $0 | 3,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-07 | 2022-01-07 | 3,250 | — | $0 | 12,629 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-07 | 2022-01-07 | 1,539 | $128.87 | $198.3K | 11,090 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-07 | 2022-01-07 | 1,000 | — | $0 | 4,437 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-06 | 2022-01-07 | 3,750 | — | $0 | 7,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-06 | 2022-01-07 | 1,250 | — | $0 | 2,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-06 | 2022-01-07 | 3,750 | — | $0 | 11,217 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-06 | 2022-01-07 | 1,838 | $123.86 | $227.7K | 9,379 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-06 | 2022-01-07 | 1,250 | — | $0 | 3,437 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-12-15 | 2021-12-16 | 6,996 | — | $0 | 11,538 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-12-15 | 2021-12-16 | 14,923 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-12-15 | 2021-12-16 | 14,923 | $10.82 | $161.5K | 29,386 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-12-15 | 2021-12-16 | 6,996 | $20.79 | $145.4K | 14,463 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2021-12-15 | 2021-12-16 | 20,330 | $105.43 | $2.14M | 9,056 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2021-12-15 | 2021-12-16 | 1,589 | $106.17 | $168.7K | 7,467 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-12-14 | 2021-12-16 | 3,577 | — | $0 | 14,923 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-12-14 | 2021-12-16 | 3,362 | — | $0 | 18,534 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-12-14 | 2021-12-16 | 3,362 | $20.79 | $69.9K | 10,829 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2021-12-14 | 2021-12-16 | 6,939 | $105.02 | $728.7K | 7,467 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-12-14 | 2021-12-16 | 3,577 | $10.82 | $38.7K | 14,406 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-11-25 | 2021-11-26 | 3,375 | — | $0 | 3,375 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-11-25 | 2021-11-26 | 3,375 | — | $0 | 9,066 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2021-11-25 | 2021-11-26 | 1,599 | $115.55 | $184.8K | 7,467 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-01-06 | 2021-01-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-01-06 | 2021-01-08 | 1,250 | — | $0 | 3,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-01-06 | 2021-01-08 | 3,750 | — | $0 | 11,250 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-01-06 | 2021-01-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-01-06 | 2021-01-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-01-06 | 2021-01-08 | 1,250 | — | $0 | 2,187 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2021-01-06 | 2021-01-08 | 1,747 | $83.38 | $145.7K | 5,691 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-01-06 | 2021-01-08 | 3,750 | — | $0 | 7,438 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-11-25 | 2020-11-27 | 3,375 | — | $0 | 6,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2020-11-25 | 2020-11-27 | 1,531 | $90.14 | $138.0K | 3,688 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-11-25 | 2020-11-27 | 3,375 | — | $0 | 5,219 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-06-12 | 2020-06-12 | 16,250 | — | $0 | 48,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-06-12 | 2020-06-12 | 20,716 | — | $0 | 21,896 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-06-12 | 2020-06-12 | 16,250 | $32.42 | $526.8K | 38,810 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-06-12 | 2020-06-12 | 20,716 | $20.79 | $430.7K | 22,560 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-06-12 | 2020-06-12 | 4,351 | $63.02 | $274.2K | 34,459 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-06-12 | 2020-06-12 | 5,300 | $64.05 | $339.5K | 29,159 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-06-12 | 2020-06-12 | 11,390 | $65.80 | $749.5K | 1,844 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-06-12 | 2020-06-12 | 15,925 | $64.89 | $1.03M | 13,234 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-01-08 | 2020-01-10 | 937 | — | $0 | 2,813 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-01-08 | 2020-01-10 | 3,750 | — | $0 | 3,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-01-08 | 2020-01-10 | 937 | $55.91 | $52.4K | 937 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-12-18 | 2019-12-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-12-18 | 2019-12-20 | 3,375 | — | $0 | 10,125 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-12-18 | 2019-12-20 | 3,375 | — | $0 | 3,375 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2019-12-18 | 2019-12-20 | 1,531 | $52.13 | $79.8K | 1,844 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-11-25 | 2019-11-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-11-25 | 2019-11-27 | 13,500 | — | $0 | 13,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-10-18 | 2019-10-25 | 17,700 | — | $0 | 18,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-10-18 | 2019-10-25 | 17,700 | $10.82 | $191.5K | 17,700 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-10-18 | 2019-10-25 | 17,700 | $45.07 | $797.7K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-10-15 | 2019-10-17 | 800 | — | $0 | 36,200 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-10-15 | 2019-10-17 | 800 | $10.82 | $8.7K | 800 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-10-15 | 2019-10-17 | 800 | $45.01 | $36.0K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-09-17 | 2019-09-19 | 11,000 | — | $0 | 11,000 | SEC↗ |